Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.
Related Posts
JetBlue cuts more unprofitable routes, tweaks Europe flights
JetBlue is in the middle of a new plan to return to consistent profitability and cut costs.
Treasury Secretary Scott Bessent says Americans looking to retire aren’t concerned about day-to-day markets, dismisses concerns about a potential recession
Bessent’s comments come after President Donald Trump warned that the “economic revolution” won’t “be easy” in a social media post.
Canadians pull back on U.S. trips, threatening to widen United States’ $50 billion travel deficit
Some carriers are cutting back U.S. flights from Canada due to weaker demand.